MANILA, Philippines — The donated vaccines from China biotech firm Sinovac, which will arrive this weekend, should still undergo evaluation of the Health Technology Assessment Council (HTAC), a group of doctors from Philippine General Hospital (PGH) said Saturday.
The HTAC, an advisory body, reviews the cost, ethics and community impact of an anti-Covid-19 drug.
In a statement, the PGH Physician Association said the vaccine program should “have been handled with more prudence and transparency.”
“The PGH PA stands firm that Sinovac, despite being the only vaccine available at hand, should undergo appraisal by the Health Technology Assessment Council (HTAC) to facilitate ind…
Keep on reading: PGH physicians call for review of ethics, cost of donated Sinovac shots